Dogwood Therapeutics Inc.
DWTX | NASDAQ
$1.54
-$0.06 (-3.75%)
Sep 22, 2026, 2:08 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.96 | -0.20 | -2.04 | -0.21 | -2.67 | -3.58 |
PEG Ratio | 0.01 | 0 | 0.03 | 0.01 | 0.30 | -0.01 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.46 | 0.04 | 2.84 | 0.36 | 2.94 | 1.24 |
P/FCF Ratio | -2.19 | -0.29 | -2.22 | -0.23 | -2.72 | -9.50 |
P/OCF Ratio | -2.19 | -0.29 | -2.22 | -0.23 | -2.72 | -9.50 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0.24 | n/a | n/a | n/a | n/a |
Quick Ratio | 2.76 | 5.21 | 11.62 | 8.02 | 12.37 | 20.55 |
Current Ratio | 2.76 | 5.21 | 11.62 | 8.02 | 12.37 | 20.55 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -132.63 | n/a | n/a | n/a | -26.04 |
Return on Equity | -45.74% | -19.21% | -139.12% | -167.17% | -110.06% | -34.56% |
Return on Assets | -37.99% | -13.10% | -127.14% | -146.33% | -101.16% | -32.87% |
Return on Invested Capital | -32.09% | -13.40% | -143.08% | -168.09% | -107.86% | -33.42% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | 0.20% |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | -0.72% |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | -0.66% |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DWTX